|
|
1) Morison WL, Parrish JA, Fitzpatrick TB. Oral photochemotherapy of atopic eczema.
Br J Dermatol 98: 25-30, 1978
2) Jekler J, Larko O. Phototherapy for atopic dermatitis with ultraviolet A(UVA),
low-dose UVB and combined UVA and UVB. two paired comparison studies.
Photodermatol Photomed 8: 151-156,1991
3) Yoshiike T, Aikawa Y, Sindhvananda J, Ogawa H. J Dermatol Sci 5: 50-53, 1992
4) British Photodermatology Group. British Photodermatology Group guidelines
for PUVA 130: 246-255, 1994
5) Der-Petrossian M, Seeber A, Honigsmann H, Tanew A. Half-side comparison study
on the efficacy of 8-methoxypsoralen bath PUVA versus narrow-band ultraviolet
B phototherapy in patients with severe chronic atopic dermatitis. Br J Dermatol 142: 39-43, 2000
6) Reynolds NJ, Franklin V, Gray JC, Diffey BL, Farr PM. Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomized controlled trial. Lancet 357(9273): 2012-2016, 2001
7) Krutmann J, Diepgen TL, Luger TA, et al. High-dose UVA1 therapy for atopic dermatitis: Results of a multicenter trial. J Am Acad Dermatol 38: 589-593, 1998
8) Dittmar HC, Pflieger D, Schopf E, Simon JC. UVA1 phototherapy. Pilot study
of dose finding in acute exacerbated atopic dermatitis. Hautarzt 52: 423-427, 2001
9) Tzaneva S, Seeber A, Schwaiger M, Honigsmann H, Tanew A. High-dose versus medium-dose UVA1 phototherapy for patients with severe generalized atopic dermatitis. J Am Acad Dermatol. 45: 503-507, 2001.
10) Kirby B, Chalmers RJG. Multiple squamous cell carcinomas following photochemotherapy for atopic eczema. Cln Expl Dermatol, 24: 336, 1999
11) Stern RS, Lunder EJ. Risk of squamous cell carcinoma and methoxsalen
(psoralen) and UV-A radiation(PUVA). Arc Dermatol. 134: 1582-1585, 1998.
12) Lindelof R, Sigurgeirsson B, Tegner E, Larko O, Johannesson A, Berne B,
Christensen OB, Andersson A, Torngren M, Molin L, Nylander-Lundqvist E,
Emtestam L. PUVA and cancer: a large-scale epidemiological study. Lancet.
338, 91-93, 1991.
13) Stern RS, Laird N. The carcinogenic risk of treatment for severe psoriasis.
Cancer, 73, 2759-2764, 1994.
14) Stern RS, the PUVA Follow-up Study. The risk of melanoma in association with
long-term exposure to PUVA. J Am Acad Dermatol. 44: 755-761, 2001.
15) Lindelof B, Sigurgeirsson B, Tegner E, Larko O, Johannesson A, Berne B,
Ljunggren B, Andersson T, Molin L, Nylander-Lundqvist E, Emtestam L.
PUVA and cancer risk: the Swedish follow-up study. Br J Dermatol, 141: 108-112,
1999.
16) Hannuksela-Svahn A, Pukkala E, Koulu L, Jansen CT, Karvonen J. Cancer
incidence among Finnish psoriasis patients treated with 8-methoxypsoralen
bath PUVA. J Am Acad Dermatol, 40, 694-696,1999.
17) 日本皮膚科学会, アトピー性皮膚炎治療ガイドライン作成委員会, 川島 眞, 瀧川雅浩, 中川秀己, 古江増隆, 飯島正文, 飯塚 一, 伊藤雅章, 塩原哲夫, 竹原和彦, 玉置邦彦, 宮地良樹, 橋本公二, 吉川邦彦. 日本皮膚科学会編「アトピー性皮膚炎治療ガイドライン」日皮会誌
110，1099-1104，2000．
18) Holden CA et al. Atopic dermatitis: in Rook/Wilkinson/Ebling, Textbook of
Dermatology, 6th ed. Champion RH, Burton JL, Burns DA, Breathnach SM.
Blackwell Science, Oxford, 681-708,1998.
|
|
